Jean SS,Gould IM,Lee WS,Hsueh PR .2019 .New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship. , 79 : 705-714.
Wang B,Pan F,Wang C,Zhao W,Sun Y .2020 .Molecular epidemiology of Carbapenem-resistant Klebsiella pneumoniae in a paediatric hospital in China. International Journal of Infectious Diseases, 93 : 311-319.
Carbapenem-Resistant Enterobacteriaceae Alotaibi F. .2019 .An update narrative review from Saudi Arabia. Journal of Infection and Public Health, 12(4) : 465-471.
Lee CR,Lee JH,Park KS,Kim YB,Jeong BC,Methods Detection .2016 .Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options,. , 7 : 895.
Wang Z,Ma K,Chen Z,Guo Z,Zhao G .2020 .Successful Treatment of Early Post-Transplant Bloodstream and Pulmonary Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With a Combination of CeftazidimeAvibactam and Carbapenem: A Case Report. , 52(9) : 2742-2746.
Munoz-Price LS,Poirel L,Bonomo RA,Schwaber MJ,Daikos GL .2013 .Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. The Lancet Infectious Diseases, 13(9) : 785-796.
Mantilla-Calderon D,Jumat MR,Wang T,Ganesan P,AlJassim N .2016 .Isolation and Characterization of NDMPositive Escherichia coli from Municipal Wastewater in Jeddah, Saudi Arabia. Antimicrobial Agents and Chemotherapy, 60(9) : 5223-5231.
Bush K,Jacoby GA .2010 .Updated functional classification of β- lactamases. Antimicrobial Agents and Chemotherapy, 54(3) : 969-976.
Agents Antimicrobial .2018 .. , 62(10) : e01076-18.
Bush K. .2015 .A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. International Journal of Antimicrobial Agents, 46(5) : 483-493.
Kazmierczak KM,Bradford PA,Stone GG,de Jonge BLM,Sahm DF BLM .2015 .In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from. , : .
Agents Antimicrobial .2018 .. , 62(12) : e00592-18.
Davido B,Fellous L,Lawrence C,Maxime V,Rottman M .2017 .Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo- β-Lactam resistance conferred by metallo-β- lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 61(9) : e01008-17.
Marshall S,Hujer AM,Rojas LJ,Papp-Wallace KM,Humphries RM .2017 .Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? Antimicrobial Agents. , 61(4) : e02243-16.
Bocanegra-Ibarias P,Camacho-Ortiz A,Garza-González E,Flores-Treviño S,Kim H .2020 .Aztreonam plus ceftazidimeavibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy. Journal of Global Antimicrobial Resistance, 23 : 417-419.
Rosa R,Rudin SD,Rojas LJ,Perez-Cardona A,Aragon L .2017 .Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient. Clinical Infectious Diseases, 65(4) : 701-702.
Pragasam AK,Veeraraghavan B,Shankar BA,Bakthavatchalam YD,Mathuram A .2019 .Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study. Indian journal of medical microbiology, 37(1) : 34-41.
Zhang W,Guo Y,Li J,Zhang Y,Yang Y .2018 .In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing Klebsiella pneumoniae. Antimicrobial Resistance and Infection Control, 7 : 142.
Emeraud C,Escaut L,Boucly A,Fortineau N,Bonnin RA .2019 .Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-LactamaseProducing Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy, 63(5) : e00010-19.
Wayne PA,Logan LK,Bonomo RA .2016 .; 3(2): ofw090.. , 294 : .
Padhi S .2011 .New Delhi metallo-beta-lactamase: a weapon for the newly emerging drug-resistant bacteria. Indian Journal of Medical Sciences, 65(8) : 317-320.
Balkhy HH,El-Saed A,Alshamrani MM,Alsaedi A,Al Nasser W .2020 .Antimicrobial Resistance and Infection Control, (. , 9(1) : 1-12.
Alghoribi MF,Binkhamis K,Alswaji AA,Alhijji A,Alsharidi A .2020 .Genomic analysis of the first KPC-producing Klebsiella pneumoniae isolated from a patient in Riyadh: A new public health concern in Saudi Arabia. Journal of Infection and Public Health, 13(4) : 647-650.
Hala S,Antony CP,Alshehri M,Althaqafi AO,Alsaedi A .2019 .First report of Klebsiella quasipneumoniae harboring bla (KPC-2) in Saudi Arabia. Antimicrobial Resistance and Infection Control, 8 : 1-8.
van Duin D,Doi Y. .2017 .The global epidemiology of carbapenemase-producing Enterobacteriaceae. , 8(4) : 460-469.
Karakonstantis S,Kritsotakis EI,Gikas A .2020 .Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options. Journal of Antimicrobial Chemotherapy, 75(2) : 271-282.
Falcone M,Daikos GL,Tiseo G,Bassoulis D,Giordano C .2021 .Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β- lactamase-Producing Enterobacterales. Clinical infectious diseases. , 72(11) : 1871-1878.
Tamma PD,Aitken SL,Bonomo RA,Mathers AJ,van Duin D .2023 .Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clinical infectious diseases. Infectious Diseases Society of America, : ciad428.
de Jonge BL,Karlowsky JA,Kazmierczak KM,Biedenbach DJ,Sahm DF .2016 .In Vitro Susceptibility to CeftazidimeAvibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (. Antimicrobial Agents and Chemotherapy, 60(5) : 3163-3169.
Agents Antimicrobial .2015 .. , 59(3) : 1789-1793.
Agents Antimicrobial .2016 .. , 60(6) : 3601-3607.
Hellmark B,Unemo M,Nilsdotter-Augustinsson A,Söderquist B. .2010 .In vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid. European Journal of Clinical Microbiology & Infectious Diseases, 29 : 591-595.
.2017 .Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gramnegative pathogens. Diagnostic Microbiology and Infectious Disease, 88(4) : 352-354.
. .To read the copy of this license please visit: https://creativecommons. , : .